Concepedia

Vijay Chiruvolu

VC

Statistics

Publications

3

Citations

46

H-Index

3

Active since

2016

Affiliations

Kite (United States)(Current)

Vijay Chiruvolu is an author at Kite (United States) specializing in immunotherapy, life sciences, and immunology.

Publications per year

2016–2018

3

Publications

3

Production of Anti-CD19 CAR T Cells for ZUMA-3 and -4: Phase 1/2 Multicenter Studies Evaluating KTE-C19 in Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R ALL)

Marianna Sabatino, Kenny Choi, Vijay Chiruvolu et al. · Blood · 2016 · 24 citations

, , +17

287. Production of KTE-C19 (Anti-CD19 CAR T Cells) for ZUMA-1: A Phase 1/2 Multi-Center Study Evaluating Safety and Efficacy in Subjects with Refractory Aggressive Non-Hodgkin Lymphoma (NHL)

Marc Better, Vijay Chiruvolu, James Oliver et al. · Molecular Therapy · 2016 · 11 citations · Full text

, , +17

Overcoming Challenges for Engineered Autologous T Cell Therapies

Marc Better, Vijay Chiruvolu, Marianna Sabatino · Cell and Gene Therapy Insights · 2018 · 11 citations

, , +12

1–3 of 3